Long-term survival in metastatic gastric cancer patient with Apatinib plus S-1 maintenance treatment following first-line chemotherapy—case report
The current treatment of advanced gastric cancer is not satisfactory. The combined application of S-1 and Apatinib in gastric cancer maintenance therapy deserves further study. Maintenance therapy for gastric cancer has attracted wide attention, and more large-scale clinical research is under way.
Authors
- Chenchen Fang
- M. Wu (ORCID: https://orcid.org/0009-0003-1021-0220)
- Manqing Hu
- Yue Guan (ORCID: https://orcid.org/0000-0001-6377-4626)
- Hao Li (ORCID: https://orcid.org/0000-0003-3796-6952)
- Maopeng Yang
- Huaxing Wu
- Zhen Wang (ORCID: https://orcid.org/0000-0002-2488-2234)
Institutions
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- The Central Hospital of Xiao gan (CN)
- Fourth Affiliated Hospital of Harbin Medical University (CN)
- Wuhan University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-18
- DOI
- https://doi.org/10.3389/fonc.2024.1478719
- Citations
- 2
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.84